"Demand is growing every year. This is driven by the fact that most Southeast Asian countries struggle to meet annual production targets, creating a gap for improvements."
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.